Kioxia Corporation, a world leader in memory solutions, today announced that it has commenced sample shipments of 1Tb ...
Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival. Efficacy and harms results support the use of [177Lu]Lu-edotreotide in early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results